Preferred Label : piroxicam;
MeSH definition : A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is
well established in treating rheumatoid arthritis and osteoarthritis and used for
musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life
enables it to be administered once daily.;
MeSH hyponym : CP-16171; feldene; CP 16171; CP16171;
MeSH CAS label : 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide;
MeSH Related Number : 36322-90-4 (Piroxicam);
Registry Number MeSH : 36322-90-4;
Wikipedia link : https://en.wikipedia.org/wiki/Piroxicam;
Codes EINECS : 252-974-3;
Is substance : O;
UNII : 13T4O6VMAM;
InChIKey : QYSPLQLAKJAUJT-UHFFFAOYSA-N;
Origin ID : D010894;
UMLS CUI : C0031990;
ATC code(s)
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
- W7477 [MeSH Supplementary Concept]
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is
well established in treating rheumatoid arthritis and osteoarthritis and used for
musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life
enables it to be administered once daily.
http://www.has-sante.fr/portail/jcms/c_2625591/fr/feldene-geldene
2016
false
France
French
tendinitis
sprains and strains
piroxicam
anti-inflammatory agents, non-steroidal
piroxicam
anti-inflammatory agents, non-steroidal
arthritis, rheumatoid
spondylitis, ankylosing
osteoarthritis, hip
osteoarthritis, knee
treatment outcome
insurance, health, reimbursement
piroxicam
evaluation of the transparency committee
tendinopathy
---
http://www.lecrat.eu/?s=Etat+des+connaissances+sur+le+piroxicam
France
drug information
knowledge
piroxicam
pregnancy, high-risk
teratogens
pregnancy, nos
---
http://www.lecrat.eu/?s=Piroxicam
2013
France
French
pregnancy
piroxicam
anti-inflammatory agents, non-steroidal
piroxicam
drug information
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69052120
2012
France
summary of product characteristics
package leaflet
piroxicam
capsules
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62096096
2012
France
summary of product characteristics
package leaflet
capsules
piroxicam
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64904473
2012
France
summary of product characteristics
package leaflet
piroxicam
capsules
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60288614
2012
France
summary of product characteristics
package leaflet
piroxicam
capsules
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67785736
2012
France
summary of product characteristics
package leaflet
piroxicam
tablets
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69482905
2012
France
summary of product characteristics
package leaflet
capsules
piroxicam
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69405104
2012
France
summary of product characteristics
package leaflet
piroxicam
suppositories
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62651719
2012
France
summary of product characteristics
package leaflet
piroxicam
capsules
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61388069
2012
France
summary of product characteristics
package leaflet
capsules
piroxicam
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63579500
2012
France
summary of product characteristics
package leaflet
capsules
piroxicam
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69721369
2012
France
summary of product characteristics
package leaflet
piroxicam
injections
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63484333
2012
France
summary of product characteristics
package leaflet
capsules
piroxicam
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67358008
2012
France
summary of product characteristics
package leaflet
capsules
piroxicam
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62486915
2012
France
summary of product characteristics
package leaflet
capsules
piroxicam
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67634588
2012
France
summary of product characteristics
package leaflet
piroxicam
capsules
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69901011
2012
France
summary of product characteristics
package leaflet
capsules
piroxicam
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65523393
2012
France
summary of product characteristics
package leaflet
capsules
piroxicam
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62408891
2012
France
summary of product characteristics
package leaflet
piroxicam
injections
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62290603
2012
France
summary of product characteristics
package leaflet
piroxicam
tablets
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68659391
2012
France
summary of product characteristics
package leaflet
capsules
piroxicam
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62746964
2012
France
summary of product characteristics
package leaflet
piroxicam
powders
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62601506
2012
France
summary of product characteristics
package leaflet
piroxicam
capsules
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62196004
2012
France
summary of product characteristics
package leaflet
piroxicam
capsules
---
http://www.has-sante.fr/portail/jcms/c_1277879/brexin
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-07/brexin_04072012_avis_ct8619.pdf
http://www.has-sante.fr/portail/jcms/c_798087/brexin
http://www.has-sante.fr/portail/jcms/c_400853/brexin-20-mg-comprime-secable-boite-de-14-comprimes-code-cip-335-959-8
http://www.has-sante.fr/portail/jcms/c_399610/brexin-20-mg-comprime-effervescent-boite-de-14
2012
France
French
evaluation of the transparency committee
piroxicam-beta-cyclodextrin
piroxicam
administration, oral
insurance, health, reimbursement
beta-cyclodextrins
anti-inflammatory agents, non-steroidal
piroxicam
osteoarthritis
arthritis, rheumatoid
spondylitis, ankylosing
treatment outcome
---
http://www.has-sante.fr/portail/jcms/c_1277955/cycladol
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-07/cycladol_20062012_avis_ct12037.pdf
http://www.has-sante.fr/portail/jcms/c_798077/cycladol
http://www.has-sante.fr/portail/jcms/c_538675/cycladol
cycladol-20-mg-comprime-effervescent-boite-de-14
2012
France
French
evaluation of the transparency committee
piroxicam-beta-cyclodextrin
anti-inflammatory agents, non-steroidal
administration, oral
insurance, health, reimbursement
beta-cyclodextrins
piroxicam
piroxicam
arthritis, rheumatoid
osteoarthritis
spondylitis, ankylosing
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-12/proxalyoc_30-11-2011_avis_ct-10824.pdf
http://www.has-sante.fr/portail/jcms/c_468401/proxalyoc
http://www.has-sante.fr/portail/jcms/c_399112/proxalyoc
http://www.has-sante.fr/portail/jcms/c_1147513/proxalyoc
2011
France
French
evaluation of the transparency committee
piroxicam
administration, oral
insurance, health, reimbursement
piroxicam
anti-inflammatory agents, non-steroidal
cyclooxygenase inhibitors
osteoarthritis
arthritis, rheumatoid
spondylitis, ankylosing
treatment outcome
---
http://www.cochrane.org/fr/CD007591
2010
false
true
false
United Kingdom
France
piroxicam
treatment outcome
review of literature
french abstract
tenoxicam
adult
pain, postoperative
---
http://www.cochrane.org/fr/CD002762
2010
false
true
false
United Kingdom
France
piroxicam
treatment outcome
review of literature
french abstract
piroxicam
pain, postoperative
---
http://www.has-sante.fr/portail/jcms/c_834675/brexin-cycladol-feldene-proxalyoc-piroxicam-anti-inflammatoire-non-steroidien
2009
false
France
French
piroxicam
anti-inflammatory agents, non-steroidal
piroxicam
anti-inflammatory agents, non-steroidal
arthritis, rheumatoid
spondylitis, ankylosing
osteoarthritis, hip
osteoarthritis, knee
treatment outcome
insurance, health, reimbursement
piroxicam
evaluation of the transparency committee
guidelines for drug use
---
http://www.has-sante.fr/portail/jcms/c_798084/proxalyoc
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-05/proxalyoc_-_ct-6027.pdf
2009
France
French
piroxicam
administration, oral
piroxicam
osteoarthritis
arthritis, rheumatoid
anti-inflammatory agents, non-steroidal
spondylitis, ankylosing
treatment outcome
piroxicam
anti-inflammatory agents, non-steroidal
insurance, health, reimbursement
evaluation of the transparency committee
---
http://www.cochrane.org/fr/CD007441/dose-unique-de-lornoxicam-commercialise-sous-les-denominations-xefo-xafon-lorcam-et-acabel-pour-la
2009
false
false
United Kingdom
France
French
meta-analysis
pain, postoperative
acute pain
treatment outcome
anti-inflammatory agents, non-steroidal
piroxicam
lornoxicam
administration, oral
adult
french abstract
---
http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F34F11E
2007
Belgium
journal article
health personnel
correspondence as topic
attention
piroxicam
---
http://www.has-sante.fr/portail/display.jsp?id=c_460074
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032676.pdf
2006
France
French
piroxicam
administration, oral
anti-inflammatory agents, non-steroidal
insurance, health, reimbursement
piroxicam
adult
adolescent
evaluation of the transparency committee
---